Page last updated: 2024-08-21

pyrazines and pyrazolanthrone

pyrazines has been researched along with pyrazolanthrone in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dent, P; Grant, S; Rahmani, M; Yu, C1
Chizzolini, C; Dayer, JM; Fineschi, S; Guerne, PA; Reith, W1
Bagain, L; Chen, Z; Lee, TL; Malhotra, PS; Nottingham, L; Ricker, JL; Van Waes, C; Yeh, NT1
Jiao, BM; Li, ZL; Qian, HJ; Su, L; Zheng, JS1
Bai, QX; Zhang, XY1
Gu, Y; Hu, Y; Shen, Y; Shu, Y; Sun, Y; Wang, L; Wu, X; Xu, Q1
Gao, X; Ma, W; Wang, Y; Zhang, X; Zhong, M1

Other Studies

7 other study(ies) available for pyrazines and pyrazolanthrone

ArticleYear
The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib.
    Experimental cell research, 2004, May-01, Volume: 295, Issue:2

    Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Caspases; Cytochromes c; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia; MAP Kinase Signaling System; Membrane Potentials; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Models, Biological; Protease Inhibitors; Pyrazines; Pyridines; Reactive Oxygen Species; Signal Transduction; U937 Cells

2004
Proteasome blockade exerts an antifibrotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal fibroblasts.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006, Volume: 20, Issue:3

    Topics: Acetylcysteine; Anthracenes; Boronic Acids; Bortezomib; Collagen Type I; Dose-Response Relationship, Drug; Down-Regulation; Extracellular Matrix; Fibroblasts; Fibrosis; Genes, jun; Humans; JNK Mitogen-Activated Protein Kinases; Leupeptins; Matrix Metalloproteinase 1; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-jun; Pyrazines; RNA Polymerase II; RNA, Messenger; Scleroderma, Systemic; Skin; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Up-Regulation

2006
Differential bortezomib sensitivity in head and neck cancer lines corresponds to proteasome, nuclear factor-kappaB and activator protein-1 related mechanisms.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:7

    Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Cycle; Cell Line, Tumor; Drug Synergism; Genes, Reporter; Head and Neck Neoplasms; Humans; Keratinocytes; Mice; Mice, Inbred BALB C; NF-kappa B; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Signal Transduction; Transcription Factor AP-1; Ubiquitination; Xenograft Model Antitumor Assays

2008
[The influence of JNK inhibitor on hemodynamics after ischemia/reperfusion injury to the heart in rats].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2008, Volume: 20, Issue:12

    Topics: Animals; Anthracenes; Disease Models, Animal; Hemodynamics; JNK Mitogen-Activated Protein Kinases; Male; Myocardial Reperfusion Injury; Protein Kinase Inhibitors; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley

2008
Curcumin enhances cytotoxic effects of bortezomib in human multiple myeloma H929 cells: potential roles of NF-κB/JNK.
    International journal of molecular sciences, 2012, Volume: 13, Issue:4

    Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Curcumin; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Multiple Myeloma; p38 Mitogen-Activated Protein Kinases; Pyrazines; Transcription Factor RelA

2012
Preferential cytotoxicity of bortezomib toward highly malignant human liposarcoma cells via suppression of MDR1 expression and function.
    Toxicology and applied pharmacology, 2015, Feb-15, Volume: 283, Issue:1

    Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Survival; Cycloheximide; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Liposarcoma; MAP Kinase Kinase 4; Mice, Nude; Protein Kinase Inhibitors; Pyrazines; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Tumor Burden; Xenograft Model Antitumor Assays

2015
Tetramethyl Pyrazine Protects Hippocampal Neurons Against Anoxia/Reoxygenation Injury Through Inhibiting Apoptosis Mediated by JNK/MARK Signal Pathway.
    Medical science monitor : international medical journal of experimental and clinical research, 2016, Dec-23, Volume: 22

    Topics: Animals; Anthracenes; Apoptosis; Cells, Cultured; Hippocampus; Hypoxia; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Neurons; Neuroprotective Agents; Oxygen; Phosphorylation; Pyrazines; Rats, Sprague-Dawley; RNA, Messenger

2016